SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Adline Chem Lab Ltd (524604) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 524604 NSE: | Pharmaceuticals & Drugs | Small Cap

Adline Chem Lab Share Price

10.75 0.00 (0.00%)
As on 16-Apr'26 16:59

Adline Chem Lab Ltd (524604)

BSE: 524604 NSE:
Key Metrics
Market Cap
₹6 Cr.
P/E Ratio
0.00
Price to Book (P/B)
-3.91
Price to Sales (P/S)
0.00
EV/EBITDA
-1928.34
Return on Capital Employed (ROCE)
0.00%
Current Price
₹10.8
Return on Equity (ROE)
0.00%
Return on Assets (ROA)
-224.83%
Operating Profit Margin
0%
Net Profit Margin
-INF%
Gross Profit Margin
0%
Book Value per Share
₹-2.8
Sales Growth (YoY)
NA%
Sales Growth (3 Years)
-100%
Operating Profit Growth (1 Year)
NA%
Operating Profit Growth (3 Years)
N/A%
Net Profit Growth (1 Year)
NA%
52-Week Low / High
₹8 / 19
Net Profit Growth (3 Years)
NAN%
Dividend Yield
0.00%
Promoter Holding
25.85%
Pledged shares (%)
of Promoter's holding (%)
0.00%

Check Before You Invest

Q.1 Revenue growth of Adline Chem Lab Ltd?
Adline Chem Lab Ltd revenue growth is 0% for FY-2025 , which is above its 5 year CAGR of -100% , indicating faster growth.
Q.1 Promoter shareholding and pledge status of Adline Chem Lab Ltd?
Promoters hold 25.85% of the Adline Chem Lab Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Revenue growth of Adline Chem Lab Ltd vs industry peers?
Adline Chem Lab Ltd revenue CAGR is -100.00% , compared to the industry median CAGR of 5.54% , indicating slower growth and losing its market share.
Q.1 Which industry/sub-sector does Adline Chem Lab Ltd belong to?
Adline Chem Lab Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.1 Stock return of Adline Chem Lab Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 16.08% based on the current price.

DeciZen - make an informed investing decision on Adline Chem Lab

Based on:

M-Cap below 100cr DeciZen not available

Adline Chem Lab stock performance

Key Ratios
mw4me loader

Is Adline Chem Lab Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Adline Chem Lab Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 3.2%2.5%2.6%0.9%-49.4%-23.8%16.2%-227%0%0%-
Value Creation
Index
-0.8-0.8-0.8-0.9-4.5-2.70.2NANANA-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 16.716.98.15.66.66.30.70000
Sales YoY Gr.-1.1%-52%-31%17.9%-4%-88.3%-100%NANA-
Adj EPS 0000-6.7-2.21.2-2-0.5-0.2-0.1
YoY Gr.--66.7%-100%NA-16925%NANA-265.9%NANA-
BVPS (₹) 8.26.14.64.65.53.34.5-2.7-2.4-2.6-2.8
Adj Net
Profit
0000-3.9-1.30.7-1.2-0.3-0.1-0
Cash Flow from Ops. 0.82.51.1-1-11.3-0.30.20-0.2-0.2-
Debt/CF from Ops. 10.8410.8-5.7-0.3-8.56.296.1-8-6.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -100%-100%-100%NA
Adj EPS -225.4%NA-157.2%NA
BVPS-187.8%-185.8%-182.6%NA
Share Price - 16.1% 25.8% 3.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
0.20.100.3-76.8-49.931.4-220.718.59.23.8
Op. Profit
Mgn %
2.67.28.79.8-50.5-3.7-40.2000NAN
Net Profit
Mgn %
0.10.100.4-59.7-20.397.4000-INF
Debt to
Equity
1.92.84.220.91.30.5-0.9-1-1-
Working Cap
Days
1311102173382261416300000
Cash Conv.
Cycle
63561442421561044450000

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) -0.1 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹) -2.8 -
Reserves (₹ Cr.) -7 -
P/BV -3.91 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 7.60 / 19.08
All Time Low / High (₹) 4.75 / 28.97
Market Cap (₹ Cr.) 6.3
Equity (₹ Cr.) 5.9
Face Value (₹) 10
Industry PE 42.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Adline Chem Lab - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales16.6716.868.105.596.596.330.74000
Operating Expenses + 16.2315.647.405.059.926.561.030.800.180.29
Manufacturing Costs0.340.340.240.170.410.130.05000
Material Costs13.0512.764.611.424.883.030.480.2600
Employee Cost 1.381.151.201.331.781.560.170.050.040.18
Other Costs 1.461.391.352.122.861.840.330.490.130.12
Operating Profit 0.431.220.700.55-3.33-0.24-0.30-0.80-0.18-0.29
Operating Profit Margin (%) 2.6%7.2%8.7%9.8%-50.5%-3.7%-40.2%---
Other Income + 0.110.080.380.290.020.010.18100.25
Exceptional Items 00000.2401.14-4.3500
Interest 0.440.320.340.070.020.030.0100.120.16
Depreciation 0.090.960.730.730.421.020.350.0900
Profit Before Tax 0.020.010.010.03-3.51-1.280.67-4.23-0.30-0.21
Tax 0.0100.0100.260-0.050-0.03-0.07
Profit After Tax 0.010.0100.03-3.76-1.280.72-4.23-0.27-0.13
PAT Margin (%) 0.1%0.1%0.0%0.5%-57.1%-20.3%97.4%---
Adjusted EPS (₹)0.00.00.00.1-6.4-2.21.2-7.2-0.5-0.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 7.067.047.037.033.211.932.65-1.57-1.37-1.49
Share Capital 5.855.855.855.855.855.855.855.855.855.85
Reserves 1.211.191.181.18-2.64-3.92-3.20-7.42-7.22-7.34
Debt +9.019.9411.325.352.852.501.321.331.361.49
Long Term Debt4.294.153.770000001.49
Short Term Debt4.725.797.555.352.852.501.321.331.360
Minority Interest0000000000
Trade Payables1.481.720.801.700.560.240.45000
Others Liabilities 0.872.254.217.770.960.970.460.300.060.08
Total Liabilities 18.4220.9623.3621.857.585.634.870.060.040.08

Fixed Assets

Net Fixed Assets +10.2712.6812.4511.994.783.644.43000
Gross Block15.2718.6519.1819.466.295.635.57000
Accumulated Depreciation55.986.737.481.511.991.14000
CWIP 0.20000000000
Investments 0000000000
Inventories1.651.942.293.241.090.390.26000
Trade Receivables2.502.652.282.081.431.580.07000
Cash Equivalents flag 0.220.131.680.170.05-0.160.050.060.040.06
Others Assets 3.583.564.654.370.230.170.06000.01
Total Assets 18.4220.9623.3621.857.585.634.870.060.040.08

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 0.832.461.05-0.95-11.34-0.290.210.01-0.17-0.23
PBT 0.010.010.010.03-3.76-1.280.72-4.23-0.30-0.21
Adjustment 0.441.280.900.800.201.06-0.834.450.12-0.10
Changes in Working Capital 0.391.170.14-1.78-7.77-0.070.32-0.20.01-0.02
Tax Paid 0000000000.10
Cash Flow From Investing Activity + -0.21-3.18-3.03-0.2811.240.120000
Capex -0.21-3.19-0.53-0.2911.240.120000
Net Investments 0000000000
Others 00-2.500.01000000
Cash Flow From Financing Activity + -0.780.633.54-0.29-0.02-0.03-0.0100.150.25
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid -0.44-0.32-0.34-0.07-0.02-0.03-0.010-0.12-0.13
Dividend Paid 0000000000
Others -0.340.953.88-0.2200000.270.38
Net Cash Flow -0.15-0.091.56-1.51-0.12-0.210.200.01-0.020.02

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)0.20.210.061.02-127.09-49.8931.35N/AN/AN/A
ROCE (%)3.162.462.550.93-49.36-23.8216.18N/AN/AN/A
Asset Turnover Ratio0.910.870.370.250.450.960.14000
PAT to CFO Conversion(x)83246N/A-31.67N/AN/A0.29N/AN/AN/A
Working Capital Days
Receivable Days53551101429787410000
Inventory Days43389518012043161000
Payable Days39461003208448260000

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Adline Chem Lab Ltd FAQs

The current trading price of Adline Chem Lab on 16-Apr-2026 16:59 is ₹10.75.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 15-Apr-2026 the market cap of Adline Chem Lab stood at ₹6.29 Cr

The latest P/E ratio of Adline Chem Lab as of 15-Apr-2026 is 0.00.

The latest P/B ratio of Adline Chem Lab as of 15-Apr-2026 is -3.91.

The 52-week high of Adline Chem Lab is ₹19.08 and the 52-week low is ₹7.60.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Adline Chem Lab is ₹0.00 ( Cr.) .

About Adline Chem Lab Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×